Jove
Visualize
Contact Us

Related Experiment Videos

[Neuroleptics and cognition].

Alexander Brunnauer1, Elisabeth Geiger, Gerd Laux

  • 1Bezirksklinikum Gabersee, Abteilung Neuropsychologie, 83512 Wasserburg/Inn. Brunnauer.Alexander@gabersee.de

Psychiatrische Praxis
|September 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

Pharmacopsychiatry·2026
Same author

[Mental diseases and driving ability-An update].

Der Nervenarzt·2026
Same author

Case Report: Effect of medicinal cannabis on fitness to drive in a patient with Tourette Syndrome and ADHD.

Frontiers in psychiatry·2025
Same author

The impact of aerobic endurance training on cognitive performance in schizophrenic inpatients in a clinical routine setting.

European archives of psychiatry and clinical neuroscience·2024
Same author

The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial.

Cannabis and cannabinoid research·2024
Same author

Driving-related cognitive skills during antidepressant transcranial direct current stimulation: results in a subsample from the DepressionDC trial.

Frontiers in psychiatry·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Atypical antipsychotics significantly improved cognitive function, particularly short-term memory and retention, in schizophrenic patients compared to conventional neuroleptics under routine clinical conditions.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Schizophrenia significantly impacts cognitive functions, affecting daily life.
  • Conventional antipsychotics offer limited cognitive benefits.
  • Atypical antipsychotics are increasingly used, but their cognitive effects require further evaluation in real-world settings.

Purpose of the Study:

  • To assess the real-world effectiveness of atypical antipsychotics on cognitive function in schizophrenia.
  • To compare cognitive outcomes between atypical and conventional antipsychotic treatments.

Main Methods:

  • Neuropsychological tests were administered to 78 schizophrenic patients.
  • Cognitive domains assessed included attention, short-term and working memory, learning, long-term memory (retention), and executive function.

Related Experiment Videos

  • Data analysis considered medication type, illness severity, and patient age.
  • Main Results:

    • Atypical antipsychotics demonstrated a significantly more favorable impact on cognitive function compared to conventional neuroleptics.
    • A notable advantage of atypical antipsychotics was observed in short-term memory and retention.
    • These benefits were evident even under standard clinical care conditions.

    Conclusions:

    • Atypical antipsychotics offer a cognitive advantage over conventional neuroleptics in schizophrenia patients.
    • These findings support the use of atypical antipsychotics for improving cognitive deficits in schizophrenia within routine clinical practice.